Ardelyx, Inc. (ARDX) stock
ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3059% below fair value
$3.09−0.03 (-0.96%)
Close on Nov 13, 2026Market cap $769.99MP/E –Yield –
Ardelyx cash
Cash and short-term investments held at the end of each period.
Ardelyx's cash was $281.83M at Jun 30, 2026. For fiscal 2025 it was $264.69M, up 5.8% from the year before. Over ten years it grew 9.5% a year on average. The highest annual figure on record is $264.69M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $264.69M | +5.8% |
| FY2024 | Dec 31, 2024 | $250.10M | +35.7% |
| FY2023 | Dec 31, 2023 | $184.30M | +48.7% |
| FY2022 | Dec 31, 2022 | $123.91M | +6.2% |
| FY2021 | Dec 31, 2021 | $116.69M | -37.4% |
| FY2020 | Dec 31, 2020 | $186.48M | -24.7% |
| FY2019 | Dec 31, 2019 | $247.49M | +47.2% |
| FY2018 | Dec 31, 2018 | $168.13M | +25.4% |
| FY2017 | Dec 31, 2017 | $134.02M | -33.3% |
| FY2016 | Dec 31, 2016 | $200.89M | +87.7% |
| FY2015 | Dec 31, 2015 | $107.00M | -0.3% |
| FY2014 | Dec 31, 2014 | $107.29M | +211.6% |
| FY2013 | Dec 31, 2013 | $34.44M | +4.7% |
| FY2012 | Dec 31, 2012 | $32.90M | +205.2% |
| FY2011 | Dec 31, 2011 | $10.78M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $281.83M | +18.2% |
| Q1 FY2026 | Mar 31, 2026 | $238.07M | +11.3% |
| Q4 FY2025 | Dec 31, 2025 | $264.69M | +5.8% |
| Q3 FY2025 | Sep 30, 2025 | $242.71M | +27.5% |
| Q2 FY2025 | Jun 30, 2025 | $238.45M | +28.2% |
| Q1 FY2025 | Mar 31, 2025 | $213.95M | +5.6% |
| Q4 FY2024 | Dec 31, 2024 | $250.10M | +35.7% |
| Q3 FY2024 | Sep 30, 2024 | $190.40M | +15.3% |
| Q2 FY2024 | Jun 30, 2024 | $185.96M | +45.8% |
| Q1 FY2024 | Mar 31, 2024 | $202.58M | +55.4% |
| Q4 FY2023 | Dec 31, 2023 | $184.30M | +48.7% |
| Q3 FY2023 | Sep 30, 2023 | $165.08M | +82.2% |
| Q2 FY2023 | Jun 30, 2023 | $127.58M | +57.5% |
| Q1 FY2023 | Mar 31, 2023 | $130.37M | +45.3% |
| Q4 FY2022 | Dec 31, 2022 | $123.91M | +6.2% |
| Q3 FY2022 | Sep 30, 2022 | $90.62M | -36.0% |
| Q2 FY2022 | Jun 30, 2022 | $81.01M | -52.8% |
| Q1 FY2022 | Mar 31, 2022 | $89.70M | -49.7% |
| Q4 FY2021 | Dec 31, 2021 | $116.69M | -37.4% |
| Q3 FY2021 | Sep 30, 2021 | $141.70M | -23.6% |
| Q2 FY2021 | Jun 30, 2021 | $171.80M | -16.0% |
| Q1 FY2021 | Mar 31, 2021 | $178.22M | -20.2% |
| Q4 FY2020 | Dec 31, 2020 | $186.48M | -24.7% |
| Q3 FY2020 | Sep 30, 2020 | $185.41M | +79.1% |
| Q2 FY2020 | Jun 30, 2020 | $204.52M | +65.0% |
| Q1 FY2020 | Mar 31, 2020 | $223.25M | +47.3% |
| Q4 FY2019 | Dec 31, 2019 | $247.49M | +47.2% |
| Q3 FY2019 | Sep 30, 2019 | $103.54M | -44.5% |
| Q2 FY2019 | Jun 30, 2019 | $123.93M | -41.8% |
| Q1 FY2019 | Mar 31, 2019 | $151.55M | +18.8% |
| Q4 FY2018 | Dec 31, 2018 | $168.13M | +25.4% |
| Q3 FY2018 | Sep 30, 2018 | $186.42M | +44.2% |
| Q2 FY2018 | Jun 30, 2018 | $212.77M | +43.0% |
| Q1 FY2018 | Mar 31, 2018 | $127.54M | -26.5% |
| Q4 FY2017 | Dec 31, 2017 | $134.02M | -33.3% |
| Q3 FY2017 | Sep 30, 2017 | $129.30M | -43.8% |
| Q2 FY2017 | Jun 30, 2017 | $148.76M | – |
| Q1 FY2017 | Mar 31, 2017 | $173.47M | – |
| Q4 FY2016 | Dec 31, 2016 | $200.89M | – |
| Q3 FY2016 | Sep 30, 2016 | $230.11M | – |
See a number that looks wrong?